カテゴリ： GlobalData, アメリカ, 企業調査

Bio Techne Corp (TECH)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Bio Techne Corp (TECH) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7473
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：87
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization. It offers Western blot, enzyme-linked immunosorbent assay, and biologics platform. Bio Techne also offers controls and calibrators for hematology clinical instruments. Bio Techne’s products find application in scientific investigation of biological processes and also to identify the nature and progress of certain diseases. The company sells its products through an extensive network of distributors across the world. It caters to biotechnology research and clinical diagnostic markets. The company has subsidiaries in the UK, Canada, and China. Bio Techne is headquartered in Minneapolis, Minnesota, the US.

Bio Techne Corp (TECH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Bio Techne Corp, Medical Equipment, Deal Details 14
Venture Financing 14
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16
Exosome Diagnostics Raises USD1.5 Million in Financing Round 17
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18
Exosome Diagnostics to Raise USD25 Million in Venture Financing 19
Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 21
Exosome Diagnostics Raises US$7 Million In Venture Financing 23
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 24
Exosome Diagnostics Raises USD3 Million in Venture Financing 25
Partnerships 26
Bio-Techne Enters into Agreement with Micropoint 26
Exosome Diagnostics Enters into Agreement with Intezyne 27
Exosome Diagnostics Enters into Agreement with Merck 28
Exosome Diagnostics Enters into Agreement with Amgen 29
Exosome Diagnostics Enters into Agreement with Takeda Pharma 30
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32
Luminex Enters into Distribution Agreement with Bio-Techne 33
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44
Equity Offering 45
Astute Medical Raises USD43 Million in Private Palcement of Shares 45
ProteinSimple Withdraws IPO 46
Acquisition 47
Bio-Techne Acquires Exosome Diagnostics 47
Bio Techne Acquires Trevigen 48
Bio-Techne Acquires Advanced Cell Diagnostics 49
Bio-Techne Acquires Space Import-Export for USD9 Million 51
Bio-Techne Acquires Cliniqa 52
Bio-Techne Acquires Cyvek 53
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54
Techne Completes Acquisition Of Bionostics For US$104 Million 56
Bio Techne Corp – Key Competitors 58
Bio Techne Corp – Key Employees 59
Bio Techne Corp – Locations And Subsidiaries 60
Head Office 60
Other Locations & Subsidiaries 60
Recent Developments 62
Financial Announcements 62
Aug 07, 2018: Bio-Techne releases fourth quarter fiscal 2018 results 62
May 02, 2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results 65
Feb 06, 2018: Bio-Techne Reports Net Sales Of $154.2 million In The Second Quarter Of Fiscal 2018 67
Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 69
Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 71
May 02, 2017: Bio-Techne Releases Third Quarter Fiscal 2017 Results 74
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 76
Corporate Communications 78
Apr 24, 2018: Bio-Techne Appoints Kim Kelderman As President, Diagnostics and Genomics 78
Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 79
Product News 80
Jun 26, 2018: Bio-Techne Expands RNAscope Assay Services Portfolio to Shorten Development Times and Save Costs 80
Mar 14, 2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract 81
Nov 20, 2017: Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design 82
Other Significant Developments 83
Mar 21, 2018: Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) technology with the launch of several new and updated assays 83
Jan 30, 2018: Bio-Techne’s Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms 84
Jan 15, 2018: Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne 85
Jan 11, 2017: COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator 86
Appendix 87
Methodology 87
About GlobalData 87
Contact Us 87
Disclaimer 87

List of Tables
Bio Techne Corp, Medical Equipment, Key Facts, 2018 2
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Deals By Market, 2012 to YTD 2018 10
Bio Techne Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 14
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 16
Exosome Diagnostics Raises USD1.5 Million in Financing Round 17
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 18
Exosome Diagnostics to Raise USD25 Million in Venture Financing 19
Zephyrus Biosciences Raises USD0.3 Million in Venture Financing 20
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 21
Exosome Diagnostics Raises US$7 Million In Venture Financing 23
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 24
Exosome Diagnostics Raises USD3 Million in Venture Financing 25
Bio-Techne Enters into Agreement with Micropoint 26
Exosome Diagnostics Enters into Agreement with Intezyne 27
Exosome Diagnostics Enters into Agreement with Merck 28
Exosome Diagnostics Enters into Agreement with Amgen 29
Exosome Diagnostics Enters into Agreement with Takeda Pharma 30
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 31
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 32
Luminex Enters into Distribution Agreement with Bio-Techne 33
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 34
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 35
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 36
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 37
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 38
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 39
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 40
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 41
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 42
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 43
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 44
Astute Medical Raises USD43 Million in Private Palcement of Shares 45
ProteinSimple Withdraws IPO 46
Bio-Techne Acquires Exosome Diagnostics 47
Bio Techne Acquires Trevigen 48
Bio-Techne Acquires Advanced Cell Diagnostics 49
Bio-Techne Acquires Space Import-Export for USD9 Million 51
Bio-Techne Acquires Cliniqa 52
Bio-Techne Acquires Cyvek 53
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 54
Techne Completes Acquisition Of Bionostics For US$104 Million 56
Bio Techne Corp, Key Competitors 58
Bio Techne Corp, Key Employees 59
Bio Techne Corp, Subsidiaries 60

List of Figures
Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bio Techne Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Bio Techne Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bio Techne Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Bio Techne Corp (TECH)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • JGC Holdings Corp (1963)：企業の財務・戦略的SWOT分析
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Saras S.p.A. (SRS)：石油・ガス：M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Venture Corporation Limited：企業の戦略・SWOT・財務情報
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Neuralstem Inc：企業のM&A・事業提携・投資動向
    Neuralstem Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neuralstem Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • ABM Industries Incorporated：企業の戦略・SWOT・財務分析
    ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report Summary ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Air T Inc：企業の戦略・SWOT・財務分析
    Air T Inc - Strategy, SWOT and Corporate Finance Report Summary Air T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Power Corporation of Canada：企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nexira：戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Arsenal Holdings PLC：企業の戦略的SWOT分析
    Arsenal Holdings PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Primeline Energy Holdings Inc (PEH)：企業の財務・戦略的SWOT分析
    Summary Primeline Energy Holdings Inc (Primeline Energy) is an upstream company that explores oil and gas. The company acquires and explores crude oil and natural gas properties across China. It owns and operates exploration and development rights in two offshore blocks in the East China Sea. Primel …
  • American Express Company：企業のM&A・事業提携・投資動向
    American Express Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Express Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Sunesis Pharmaceuticals Inc (SNSS)：企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Japan Pulp and Paper Company Limited：企業の戦略・SWOT・財務情報
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Australian Leaders Fund Limited：企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Camping World Holdings, Inc. (CWH)：企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • EWE AG：石油・ガス：M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • CITIC Securities Company Limited：企業の戦略・SWOT・財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bridgestone Corporation：企業の戦略・SWOT・財務分析
    Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JSW Steel Ltd：戦略・SWOT・企業財務分析
    JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary JSW Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Iridex Corp (IRIX)：企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) operates as a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glauco …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆